Short interest in Fulcrum Therapeutics Inc (NASDAQ:FULC) decreased during the last reporting period, falling from 8.15M to 8.06M. This put 16.08% of the company's publicly available shares short.

Short interest for Fulcrum Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Fulcrum Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 759.51K shares traded per day, it would take 10.61 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.